OFI Invest Asset Management Takes $17.22 Million Position in HCA Healthcare, Inc. (NYSE:HCA)

OFI Invest Asset Management bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The fund bought 59,408 shares of the company’s stock, valued at approximately $17,220,000.

A number of other hedge funds and other institutional investors have also made changes to their positions in HCA. MML Investors Services LLC raised its position in HCA Healthcare by 31.7% in the third quarter. MML Investors Services LLC now owns 17,816 shares of the company’s stock valued at $7,241,000 after purchasing an additional 4,285 shares during the period. Meritage Group LP acquired a new position in HCA Healthcare in the third quarter valued at about $150,548,000. Galvin Gaustad & Stein LLC purchased a new stake in shares of HCA Healthcare in the 4th quarter valued at approximately $18,044,000. Alpha DNA Investment Management LLC acquired a new stake in HCA Healthcare in the 3rd quarter valued at approximately $869,000. Finally, NRI Wealth Management LC acquired a new position in HCA Healthcare during the fourth quarter worth $2,896,000. Institutional investors and hedge funds own 62.73% of the company’s stock.

HCA Healthcare Price Performance

NYSE HCA opened at $330.11 on Friday. The firm has a market capitalization of $81.27 billion, a PE ratio of 15.03, a P/E/G ratio of 1.10 and a beta of 1.68. The company’s 50 day simple moving average is $316.70 and its 200 day simple moving average is $347.49. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $417.14. The company has a debt-to-equity ratio of 69.07, a current ratio of 1.08 and a quick ratio of 0.97.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Friday, January 24th. The company reported $6.22 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same quarter last year, the business earned $5.90 EPS. As a group, equities research analysts forecast that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be paid a $0.72 dividend. The ex-dividend date is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.87%. HCA Healthcare’s payout ratio is currently 13.11%.

Insider Activity at HCA Healthcare

In other news, SVP Jennifer Berres sold 9,533 shares of the company’s stock in a transaction on Friday, February 14th. The stock was sold at an average price of $322.59, for a total transaction of $3,075,250.47. Following the transaction, the senior vice president now owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this link. 1.60% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on HCA shares. Truist Financial decreased their target price on HCA Healthcare from $430.00 to $390.00 and set a “buy” rating on the stock in a research note on Monday, January 6th. Raymond James lowered shares of HCA Healthcare from an “outperform” rating to a “market perform” rating in a research note on Friday, November 22nd. Bank of America reduced their target price on shares of HCA Healthcare from $380.00 to $370.00 and set a “buy” rating on the stock in a report on Monday, January 27th. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $380.00 price objective on shares of HCA Healthcare in a research note on Tuesday, December 17th. Finally, Morgan Stanley cut their price target on HCA Healthcare from $406.00 to $355.00 and set an “equal weight” rating on the stock in a report on Tuesday, December 17th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have issued a buy rating and two have given a strong buy rating to the company’s stock. According to data from MarketBeat, HCA Healthcare currently has an average rating of “Moderate Buy” and a consensus price target of $385.67.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.